【和元生物：参与设立5亿元产业并购基金完成工商登记】和元生物公告称，公司拟以自有资金1亿元参与设立上海和元弘盛一期创业投资合伙企业，占基金募资规模20%。近日，该基金已完成目标募集规模5亿元，并完成工商登记手续。基金存续期8年，主要投资细胞与基因治疗产业链未上市企业。本次投资预计不会对公司财务和经营造成重大不利影响，但存在投资收益不及预期风险，且基金尚未完成中基协备案。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.